← Back to All Filings

Humana Director Receives 765 Shares in RSU Vesting

Low SignificanceNovember 4, 2025 at 10:01:50 AM EST

HUMANA INC

$HUM4CIK: 0000049071

Subscribe to track HUM

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Humana Director Receives 765 Shares in RSU Vesting

Company: HUMANA INC (HUM) Form: 4 | Filed: 2025-11-04 Significance: Low

Insider: Smith Gordon Title: null | Relationship: Director

Transaction: • Type: Exercise • Shares: 765 • Price: $0.00 • Value: $0 • Owned After: 765

Key Insight: This is a routine, non-market transaction representing the vesting of Restricted Stock Units (RSUs) as part of the director's compensation. It has no market value and is not an indicator of insider sentiment.

Market Context: The transaction represents a negligible 0.0006% of shares outstanding for the $33.46B healthcare company.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: HUMANA INC (HUM)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director received shares from the vesting of Restricted Stock Units (RSUs) as part of a standard compensation plan.
  • Market Impact: Neutral. This is a routine, non-discretionary transaction with no market-moving implications.

Company Information

FieldValue
CompanyHUMANA INC
Ticker SymbolHUM
CIK0000049071
IndustryHOSPITAL & MEDICAL SERVICE PLANS

Insider Information

FieldValue
NameSmith Gordon
CIK0001311487
Title/Positionnull
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-01
Transaction CodeM (Exercise or conversion of derivative security)
Security TypeHumana Common
Shares Involved765
Price Per Share$0.00
Total Value$0
Shares Owned After765
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.0%
Shares Transacted765
% of Shares Outstanding0.0006%
Post-Transaction Ownership765 shares (0.0006% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The transaction has zero monetary value and involves a negligible number of shares relative to Humana's $33.46 billion market capitalization.
  • Ownership Concentration: The insider's resulting ownership is extremely small, representing less than 0.001% of total shares outstanding.
  • Dilution Impact: The issuance of 765 shares has a virtually non-existent dilutive effect (0.0006%) on existing shareholders.
  • Transaction Significance: The transaction is classified as low significance. It is a pre-planned, non-market event related to director compensation, as detailed in the filing's footnotes, and does not reflect a discretionary investment decision.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a routine vesting of RSUs, not an open-market purchase or sale. It provides no new information about the company's prospects or the insider's sentiment.

Volume & Sentiment

  • Expected Volume Impact: None. This was not an open-market transaction and will not affect trading volume.
  • Sentiment Indicator: Neutral. This is a standard compensation event, not a bullish or bearish signal.

Additional Context

Transaction Notes

  • Special Circumstances: The filing's footnotes confirm this transaction is related to the director's annual fee, paid in stock units that convert to common stock. This is exempt under Rule 16(b)-3(d)(1).
Topics:#SECFiling#HUM#Humana#Form4#InsiderTrading#StockAlert#RSU#Director#Investing#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.